We strongly recommend recording baseline and post-RT iron studies and anemia levels as well as hepcidin and IL-6 levels whenever possible for all prospective studies utilizing cetuximab concomitant with RT so that we can have a definite conclusion. Here, HAMP is linked to anemia.